Rare mutations in bowel cancer may identify patients with a better prognosis
21 July 2016
An international collaboration between the University of Oxford and other European institutions has uncovered a correlation between a rare mutation in bowel cancers and a better prognosis, raising the possibility that patients with such tumours may not require chemotherapy after surgery. Dr David Church was joint senior author of the study.